Facebook Linkedin Twitter
Inside Precision Medicine Marketplace Translational Research SureSelect Human All Exon

Agilent
SureSelect Human All Exon

The SureSelect Human All Exon V8 provides comprehensive and most up-to-date coverage of protein coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture exons that are omitted by other exomes on the market. Powered by machine learning-based probe design and a new production process, SureSelect Human All Exon V8 spans a 35.1 Mb target region of the human genome with an efficient end-to-end design size of only 41.6 Mb. The panel delivers excellent enrichment performance, as well as efficient, cost-effective exome sequencing. In addition, the panel is manufactured in large scale to provide consistent results for many years.



Agilent

5301 Stevens Creek Blvd
Santa Clara, CA 95051
800-227-9770
https://www.agilent.com



Category:


Features & Specs

  • Powered by machine-learning based probe design and manufactured using new production process to produce probes that will last years to provide consistent results.
  • Excellent coverage uniformity and efficient probe design enable variant calling with high confidence while reducing sequencing costs.
  • Targets the most up-to-date protein coding regions from RefSeq, GENCODE, and CCDS, including hard-to-capture exons that are omitted from other exomes, and the TERT promoter.
  • Natively supported by the Bravo Automated Liquiding Handling Platform for high-throughput sample preparation, and the Magnis NGS Prep System for complete, walkaway automation.
  • Streamlined and optimized variant analysis, interpretation, and reporting via Alissa Reporter and Alissa Interpret, providing an efficient, scalable, and highly secure cloud-based solution to trusted answers.

Features & Specs

  • Powered by machine-learning based probe design and manufactured using new production process to produce probes that will last years to provide consistent results.
  • Excellent coverage uniformity and efficient probe design enable variant calling with high confidence while reducing sequencing costs.
  • Targets the most up-to-date protein coding regions from RefSeq, GENCODE, and CCDS, including hard-to-capture exons that are omitted from other exomes, and the TERT promoter.
  • Natively supported by the Bravo Automated Liquiding Handling Platform for high-throughput sample preparation, and the Magnis NGS Prep System for complete, walkaway automation.
  • Streamlined and optimized variant analysis, interpretation, and reporting via Alissa Reporter and Alissa Interpret, providing an efficient, scalable, and highly secure cloud-based solution to trusted answers.

Related products

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine